Clinical trial
The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In…
NCT00440128 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00440128 |
|---|---|
| Title | The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer |
| Official title | A Phase I, Open-Label, Randomized, Two Period Crossover Study to Investigate the Effects of GW679769 on the Pharmacokinetics of Docetaxel in Subjects With Cancer |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Chemotherapy-Induced |
| Intervention type | Drug |
| Interventions | Docetaxel, Casopitant/Docetaxel |
| Enrollment | 12 |
| Start date | May 4, 2007 |
| Primary completion | Jul 17, 2008 |
| Completion | Jul 17, 2008 |
| First posted | Feb 26, 2007 |
| Last update posted | Aug 4, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: